As part of a feature story on centenarians, the New York Times notes research by Nir Barzilai, M.D., on the role genes play in longevity. Dr. Barzilai's research has found that centenarians are 20 times as likely as the average person to have at least one long-lived relative. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of both the Institute for Aging Research and the Nathan Shock Center of Excellence in the Basic Biology of Aging.
October 19, 2010
Der Spiegel, Germany's leading weekly news magazine, interviews Nir Barzilai, M.D., regarding his genetics research on centenarians. Dr. Barzilai notes that these "super agers" are genetically in a class by themselves, since environmental and lifestyle factors do not appear to affect their longevity. The story also profiles several of the participants in his study of more than 500 centenarians and their offspring discussing their extraordinarily long lives. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research.
September 24, 2010
The Daily Telegraph (UK) interviews Nir Barzilai, M.D., on his research with centenarians and their genetic make-up, which allows many of them to lead "unhealthy" lifestyles and still live to 100. Dr. Barzilai notes that those who live extraordinarily long lives are genetically protected from the effects of environmental factors, like smoking and a poor diet. He is in the UK to address the Royal Society in London on aging and treating age-related diseases. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and director of the Institute for Aging Research.
More coverage on this story
Daily Express
Irish Herald
The Sun (UK)
The Times (UK)
BBC Mundo (in Spanish)
The Jewish Chronicle
Marie Claire (UK)
May 11, 2010
The Daily Mail (UK) profiles Nir Barzilai, M.D., his discovery of the first human "longevity genes," and the new BBC documentary featuring his research and its treatment implications. BBC Horizon interviews Dr. Barzilai, who discusses his work and new medications developed based on it, which are intended to provide protection against age-related diseases and extend life span. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and director of the Institute for Aging Research.
More coverage on this story
The Telegraph (UK)
The Sun (UK)
Daily Mirror (UK)
Economic Times (India)
Marie Claire (UK)
February 2, 2010
MSN features research by Nir Barzilai, M.D., that identifies a potential new drug target for diabetes. The article, originally by Healthday, reports that humanin, which may prevent nerve cells from dying, may also help to improve insulin action and lower blood glucose levels. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and the director of the Institute for Aging Research.
More coverage on this story
United Press International (UPI)
July 22, 2009
TheScientist.com interviews Nir Barzilai, M.D., about a Nature study that sheds light on how diet restriction might boost life span. The study shows that a single pair of proteins, whose activity is linked to diminished food intake, is responsible for significantly increasing the lifespan of worms. In the article, Dr. Barzilai remarks on the importance of the study and its impact on future research. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Professor of Aging Research and the director of the Institute for Aging Research.
June 24, 2009
The New York Times interviews Nir Barzilai, M.D. for a front page story on a decades-long study of the health and mental acuity of individuals over 90 years old. The California study has looked at more than 14,000 people over the age of 65, including 1,000 people over the age of 90. Study results indicate that daily mental activities as well as social interactions may reduce the risk of dementia. Dr. Barzilai recently published research on the role of genetics in extreme longevity. Dr. Barzilai is director of Einstein's Institute for Aging Research.
May 22, 2009
U.S. News & World Report interviews Nir Barzilai, M.D. on new research published in the Journal of the American Medical Association showing that older people with type 2 diabetes and who have been hospitalized for severe low blood sugar may have a greater risk of developing dementia. While 32 percent of people with type 2 diabetes are at greater risk for dementia, the study does not prove any cause-and-effect link between the two conditions, according to Dr. Barzilai. Dr. Barzilai is director of Einstein's Institute for Aging Research and heads the Longevity Genes Project.
April 14, 2009
Forbes features comments by Nir Barzilai, M.D. on the role of genetics in extreme longevity. The article cites Dr. Barzilai's identification of a protein that, when present, may protect centenarians against Alzheimer's disease and diabetes. Dr. Barzilai is director of Einstein's Institute for Aging Research and heads the Longevity Genes Project.
April 7, 2009
USA Today interviews Nir Barzilai, M.D., on a story exploring the potential link between diabetes and cognitive decline. Dr. Barzilai is director of Einstein's Institute for Aging Research and heads the Longevity Genes Project.
January 28, 2009
The New York Times interviews Dr. Nir Barzilai, on research showing older adults whose parents live to be 100 or longer have dramatically lower risks of heart attack, stroke, and diabetes. Dr. Barzilai is director of Einstein's Institute for Aging Research and heads the Longevity Genes Project.
November 24, 2008
Scientific American interviews Dr. Nir Barzilai, director of Einstein's Institute for Aging Research, on genetic variables that contribute to long life. The article, entitled "Is 100 the New 80?" helps explain why some people live to age 100 and beyond.
October 28, 2008
The Wall Street Journal interviews Dr. Nir Barzilai, director of Einstein's Institute for Aging, and Dr. Jan Vijg, professor and chair of genetics, in article entitled "Secrets of the Wellderly."
September 19, 2008
The Chicago Tribune includes comments from Dr. Nir Barzilai, director of Einstein's Institute for Aging, in a story about longevity, that also notes his discovery of four genes that lend clues to why some individuals live to 100 and beyond.
September 15, 2008